According to Microbot Medical
's latest financial reports the company has a price-to-book ratio of 3.10.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 4.27 | 30.91% |
2022-12-31 | 3.26 | -12.1% |
2021-12-31 | 3.71 | 83.99% |
2020-12-31 | 2.01 | -13.04% |
2019-12-31 | 2.32 | -40.52% |
2018-12-31 | 3.90 | -1.6% |
2017-12-31 | 3.96 | -95.85% |
2016-12-31 | 95.5 | -113.18% |
2015-12-31 | -725 | -6691.86% |
2014-12-31 | 11.0 | 142.39% |
2013-12-31 | 4.54 | 3.74% |
2012-12-31 | 4.37 | 297.19% |
2011-12-31 | 1.10 | -87.61% |
2010-12-31 | 8.88 | 81.63% |
2009-12-31 | 4.89 | -3.35% |
2008-12-31 | 5.06 | 47.21% |
2007-12-31 | 3.44 | -9.63% |
2006-12-31 | 3.80 | -45.42% |
2005-12-31 | 6.97 | -2.04% |
2004-12-31 | 7.11 | -3.91% |
2003-12-31 | 7.40 | -4.59% |
2002-12-31 | 7.76 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -6.34 | -304.98% | Bahamas |
NRC Health
NRC | 15.5 | 401.75% | ๐บ๐ธ USA |